Davis K B, Chaitman B, Ryan T, Bittner V, Kennedy J W
Department of Biostatistics, University of Washington, Seattle.
J Am Coll Cardiol. 1995 Apr;25(5):1000-9. doi: 10.1016/0735-1097(94)00518-u.
This study compared the rates of coronary artery bypass graft surgery and 15-year survival for men and women after initial medical or surgical management.
There has been concern that women with coronary artery disease are managed differently than men and that men and women have a different prognosis. The Coronary Artery Surgery Study (CASS) registry is a large data base of well characterized patients with long-term follow-up.
Patients underwent cardiac catheterization at 1 of 15 hospitals during 1974 to 1979. Bypass surgery rates were based on 12,452 men and 2,366 women. Survival results were based on 6,018 men and 1,095 women with operable coronary artery disease and initial medical management and 6,922 men and 1,291 women initially managed surgically.
At 15 years, bypass surgery rates were 75% for men and 72% for women (p = 0.91). The rates remained similar after adjustment for clinical and angiographic variables. The 15-year survival rate was 50% for men and 49% for women with initial medical treatment (p = 0.53) and 52% for men and 48% for women (p = 0.004) with initial surgical treatment, a difference similar to that for operative mortality (men 2.5%, women 5.3%, p < 0.0001). Survival was improved by bypass surgery in most subgroups, with largest relative risks for high risk patients. Relative risks were similar for men and women.
The rate of bypass surgery did not differ between men and women. There were few differences in the survival of men and women. In general, both men and women with initial surgical treatment survived longer, although benefits were clinically and statistically significant only in those at high risk. The benefit was similar in both men and women.
本研究比较了初次接受药物或手术治疗的男性和女性冠状动脉搭桥手术的发生率及15年生存率。
一直有人担心,患有冠状动脉疾病的女性与男性的治疗方式不同,且男性和女性的预后也不同。冠状动脉手术研究(CASS)登记处是一个包含特征明确的患者的大型数据库,并进行了长期随访。
1974年至1979年期间,患者在15家医院中的1家接受了心导管检查。搭桥手术发生率基于12452名男性和2366名女性。生存结果基于6018名男性和1095名患有可手术治疗的冠状动脉疾病且初次接受药物治疗的女性,以及6922名男性和1291名初次接受手术治疗的女性。
15年后,男性的搭桥手术发生率为75%,女性为72%(p = 0.91)。在对临床和血管造影变量进行调整后,发生率仍相似。初次接受药物治疗的男性15年生存率为50%,女性为49%(p = 0.53);初次接受手术治疗的男性为52%,女性为48%(p = 0.004),这一差异与手术死亡率相似(男性2.5%,女性5.3%,p < 0.0001)。在大多数亚组中,搭桥手术可提高生存率,高危患者的相对风险最大。男性和女性的相对风险相似。
男性和女性的搭桥手术发生率没有差异。男性和女性的生存率差异不大。总体而言,初次接受手术治疗的男性和女性存活时间更长,尽管益处仅在高危患者中具有临床和统计学意义。男性和女性的获益相似。